GW0742 | 50mg/1,5ml

$116.00

What is GW0742?

GW0742 is a synthetic agonist of the peroxisome proliferator-activated receptor delta (PPAR-δ), investigated as a potential regulator of metabolic and energy processes. Structurally related to GW501516, GW0742 shows higher selectivity and affinity for PPAR-δ, making it a valuable subject of scientific research focused on the regulation of lipid and glucose metabolism, energy balance, and muscle oxidation. Due to its specific activity, the compound is used in laboratory settings to analyze molecular mechanisms related to mitochondrial function, metabolic flexibility, and physical endurance.

Mechanism of action of GW0742:

GW0742 selectively binds to PPAR-δ receptors—nuclear receptors involved in regulating the expression of genes linked to energy metabolism. Activation of these receptors leads to stimulation of fatty acid oxidation, improved mitochondrial activity, and increased energy efficiency in muscle tissue. In addition, GW0742 modulates glucose homeostasis and influences the lipid profile, without directly affecting the hormonal axis. This mechanism makes it of particular interest in scientific research focused on metabolic diseases, endurance training, and energy adaptation.

Potential research-supported benefits of GW0742:

GW0742 has been the subject of multiple analyses, in which the following potential effects have been observed:

  • Enhanced fat burning through stimulation of β-oxidation;
  • Increased mitochondrial activity and energy efficiency in muscles;
  • Improved glucose sensitivity and glycemic control;
  • Potential support for physical endurance;
  • Anti-inflammatory modulation via regulation of PPAR-δ-dependent pathways;
  • Maintenance of a healthy lipid profile.

Thanks to these observations, GW0742 is often included in protocols studying metabolic disorders, exercise physiology, and cardiometabolic mechanisms.

Comparison of GW0742 with other SARMs and metabolic agonists

GW0742 is a synthetic PPAR-δ agonist that is not a SARM, but it is often grouped with SARMs due to similar use in research protocols for metabolic regulation, lipid control, and endurance. It is most commonly compared with Cardarine (GW501516), Stenabolic (SR9009), and sometimes with lighter SARMs such as Ostarine (MK2866) when combined for body recomposition research goals.

Compared to Cardarine, GW0742 has a higher affinity for the PPAR-δ receptor, making it more potent in models investigating fat oxidation and improvements in mitochondrial function. Both molecules encourage the use of fats as a primary energy source, but GW0742 is often preferred in more targeted metabolic research, especially when a more selective effect on energy metabolism in muscle tissue is sought.

Relative to Stenabolic (SR9009), which acts through REV-ERBα activation and influences circadian rhythms, GW0742 is more focused on deep regulation of lipid metabolism and glucose homeostasis without direct impact on the biological clock. While SR9009 supports energy capacity and endurance via mitochondrial activity, GW0742 does so through activation of metabolic genes responsible for fatty acid oxidation.

In the context of SARMs such as Ostarine or Ligandrol, which affect muscle mass via androgen receptors, GW0742 stands out as a completely non-hormonal metabolic modulator suitable for research where the goal is fat burning, improved insulin sensitivity, and metabolic flexibility.

Dosage and application of GW0742 in research protocols:

Recommended research scheme: 5-6 units once daily, for 4–6 weeks, followed by a 2–4 week break.

1 unit = 33.33mcg.

Total amount in pen: 150 units

Possible side effects of GW0742:

While GW0742 shows promising results, it is important to consider its safety profile. Observed negative effects include:

  • Changes in lipid metabolism with prolonged application;
  • Lack of long-term data regarding chronic exposure;
  • Undesirable interactions with other PPAR-modulating compounds.

Adhering to optimal dosing and controlling the duration of application play a key role in limiting the manifestation of side effects.

Disclaimer

For research use only. Not for human consumption.

Category: Tag:
Guaranteed Safe Checkout
Shopping Cart
error: Content is protected !!
GW0742 | 50mg/1,5mlGW0742 | 50mg/1,5ml
$116.00
Scroll to Top